Baseline nausea status influences response to MT 100, but not naproxen or sumatriptan: Meta-analysis results from the MT 100 development program

被引：0
|
作者：
Plachetka, JR [1 ]
Spruill, SE [1 ]
Alexander, WJ [1 ]
机构：
[1] Pozen Inc, Chapel Hill, NC USA
来源：
HEADACHE | 2005年 / 45卷 / 06期
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：813 / 813
页数：1
相关论文
共 2 条
  • [1] Comparative efficacy of MT 100 and Sumatriptan 50 mg in treating acute migraine subjects with severe pain or nausea at baseline
    Pellegrino, R
    CEPHALALGIA, 2003, 23 (07) : 701 - 701
  • [2] Treatment effects (TEs) of EGFR monoclonal antibodies (mAbs) in metastatic colorectal cancer (mCRC) patients (pts) with KRAS, NRAS, and BRAF mutation (MT) status: Individual patient data (IPD) meta-analysis of randomized trials from the ARCAD database.
    Karapetis, Christos Stelios
    Liu, Heshan
    Sorich, Michael
    Fiskum, Jack
    Grothey, Axel
    Van Cutsem, Eric
    Maughan, Tim
    Douillard, Jean-Yves
    Jonker, Derek J.
    Bokemeyer, Carsten
    Sobrero, Alberto F.
    Chibaudel, Benoist
    Zalcberg, John Raymond
    Adams, Richard
    Buyse, Marc E.
    De Gramont, Aimery
    Shi, Qian
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15)
1